Related Experiment Video
Updated: Sep 26, 2025

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Structural and functional pulmonary impairment in treated cases of pulmonary tuberculosis: a cross-sectional study
1Graded Specialist (Respiratory Medicine), Command Hospital (Eastern Command), Kolkata, India.
Background:
Pulmonary impairment after tuberculosis treatment is seen in 40%-75% of patients despite bacteriological cure. Study aimed to find prevalence of structural and functional pulmonary impairment in a group of previously fit serving soldiers at the end of supervised institutional treatment for pulmonary tuberculosis.
Methods:
Descriptive cross-sectional study was conducted in a tertiary care center on 375 newly diagnosed patients of pulmonary tuberculosis completed treatment. They underwent spirometry and chest X ray (CXR) at end of treatment. Their lung function was classified as normal or abnormal (obstructive, restrictive, or mixed pattern). Chest radiographs were reported as normal/abnormal. Logistic regression models were used to explore the factors associated with abnormal lung function.
Results:
Functional impairment was present in 145/375 (38.7%). 115/375 (30.66%) had restrictive, 24/375 (6.4%) had mixed, and 6/375 (1.6%) had obstructive pattern on spirometry, respectively. Out of the 115 patients having restrictive pattern, 103 (89.56%) had mild restriction, 11(9.56%) had moderate restriction, and 1 (0.86%) had severe restriction. Structural impairment on CXR was present in 309/375 (82.4%) of patients. Significant factors associated with pulmonary impairment in our study were time to diagnosis (>1 month) adj odds ratio (OR) = 1.71, 95% confidence interval (CI) 1.07-2.74, sputum conversion of >2 months, Adj OR 2.52, 95% CI 1.25-5.07, and sputum/culture positivity Adj OR 1.57, 95% CI 1.02-2.42. CXR abnormality was significantly associated with sputum and/culture positivity Adj OR 4.54, 95% CI 2.28-9.03.
Conclusion:
Despite successful treatment, pulmonary impairment was present in 38.7% of patients, and structural changes evident on CXR was present in 82.4% of patients.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

